[1] Cassetti MC,Durbin A,Harris E,et al. Report of an NIAID workshop on dengue animal models[J]. Vaccine,2010,28(26):4229-4234.
[2] An J,Kimura-Kuroda J,Hirabayashi Y,et al. Development of a novel mouse model for Dengue virus infection[J]. Virology,1999,263(1):70-77.
[3] 盛子洋,王娟,吴江漫,等. 利用甲基纤维素改良的病毒噬斑技术[J]. 免疫学杂志,2012,28(4):280-283.
[4] Blaney JE Jr,Johnson DH,Manipon GG,et al. Genetic basis of attenuation of Dengue virus type 4 small plaque mutants with restricted replication in suckling mice and in SCID mice transplanted with human liver cells[J]. Virology,2002,300(1):125-139.
[5] Johnson AJ,Roehrig JT. New mouse model for Dengue virus vaccine testing[J]. J Virol,1999,73(1):783-786.
[6] Shresta S,Sharar KL,Prigozhin DM,et al. Murine model for dengue virus-induced lethal disease with increased vascular permeability[J]. J Virol,2006,80(20):10208-10217.
[7] Huang KJ,Li SY,Chen SC,et al. Manifestation of thrombocytopenia in dengue-2-virus-infected mice[J]. J Gen Virol,2000,81(Pt 9):2177-2182.
[8] Chen L,Ewing D,Subramanian H,et al. A heterologous DNA prime-Venezuelan equine encephalitis virus replicon particle boost dengue vaccine regimen affords complete protection from virus challenge in cynomolgus macaques[J]. J Virol,2007,81(21):11634-11639.
[9] Paes MV,Pinhao AT,Barreto DF,et al. Liver injury and viremia in mice infected with dengue-2 virus[J]. Virology,2005,338(2):236-246.
[10] 张复春,杨智聪. 登革热[M]. 北京:科学出版社,2008:202. |